
Lakshmi Sarada Channavajjala
Examiner (ID: 456, Phone: (571)272-0591 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1615, 1611 |
| Total Applications | 1737 |
| Issued Applications | 722 |
| Pending Applications | 210 |
| Abandoned Applications | 818 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16397263
[patent_doc_number] => 20200338121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => CARBON DIOXIDE SLOW-RELEASE PACK FOR SKIN AND METHOD OF SLOWLY RELEASING CARBON DIOXIDE TO SKIN
[patent_app_type] => utility
[patent_app_number] => 16/757251
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757251 | CARBON DIOXIDE SLOW-RELEASE PACK FOR SKIN AND METHOD OF SLOWLY RELEASING CARBON DIOXIDE TO SKIN | Oct 16, 2018 | Abandoned |
Array
(
[id] => 17726504
[patent_doc_number] => 11382869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Dextromethorphan transdermal delivery device
[patent_app_type] => utility
[patent_app_number] => 16/753471
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 23167
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 369
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753471
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753471 | Dextromethorphan transdermal delivery device | Oct 2, 2018 | Issued |
Array
(
[id] => 14134559
[patent_doc_number] => 20190101669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => NOVEL ANTI-MICROBIAL BANDAGE CONTACT LENS WITH OCULAR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/150976
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150976 | Anti-microbial bandage contact lens with ocular drug delivery | Oct 2, 2018 | Issued |
Array
(
[id] => 16221156
[patent_doc_number] => 20200246272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => PHARMACEUTICAL CARRIER DESIGN
[patent_app_type] => utility
[patent_app_number] => 16/652088
[patent_app_country] => US
[patent_app_date] => 2018-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652088 | PHARMACEUTICAL CARRIER DESIGN | Sep 27, 2018 | Abandoned |
Array
(
[id] => 14041409
[patent_doc_number] => 20190076811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => MICROCAPSULES PRODUCED FROM BLENDED SOL-GEL PRECURSORS AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/126483
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/126483 | MICROCAPSULES PRODUCED FROM BLENDED SOL-GEL PRECURSORS AND METHOD FOR PRODUCING THE SAME | Sep 9, 2018 | Abandoned |
Array
(
[id] => 14403639
[patent_doc_number] => 20190167663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Abuse Resistant Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 16/124899
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/124899 | Abuse resistant pharmaceutical compositions | Sep 6, 2018 | Issued |
Array
(
[id] => 16710262
[patent_doc_number] => 20210077409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => PHARMACEUTICAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/642742
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642742
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642742 | Pharmaceutical dosage forms | Aug 29, 2018 | Issued |
Array
(
[id] => 13729431
[patent_doc_number] => 20180369183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE
[patent_app_type] => utility
[patent_app_number] => 16/115913
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/115913 | PHARMACEUTICAL COMPOSITIONS OF DIMETHYL FUMARATE | Aug 28, 2018 | Abandoned |
Array
(
[id] => 16389269
[patent_doc_number] => 20200330210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => DEVICES, KITS AND METHODS FOR REDUCING AND/OR PREVENTING INTRA-ABDOMINAL ADHESIONS
[patent_app_type] => utility
[patent_app_number] => 16/643061
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643061 | Devices, kits and methods for reducing and/or preventing intra-abdominal adhesions | Aug 27, 2018 | Issued |
Array
(
[id] => 13955331
[patent_doc_number] => 20190054009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => DAILY FORMULATION OF LACOSAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/106655
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106655 | DAILY FORMULATION OF LACOSAMIDE | Aug 20, 2018 | Abandoned |
Array
(
[id] => 15492893
[patent_doc_number] => 20200046635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/100048
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100048 | Oral cholestyramine formulation and use thereof | Aug 8, 2018 | Issued |
Array
(
[id] => 13586279
[patent_doc_number] => 20180344688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Dosage Delivery Film
[patent_app_type] => utility
[patent_app_number] => 16/058669
[patent_app_country] => US
[patent_app_date] => 2018-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16058669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/058669 | Dosage delivery film | Aug 7, 2018 | Issued |
Array
(
[id] => 15960289
[patent_doc_number] => 20200163896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => FLOATABLE PHARMACEUTICAL MICROCAPSULE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/635310
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635310 | FLOATABLE PHARMACEUTICAL MICROCAPSULE COMPOSITION | Aug 1, 2018 | Abandoned |
Array
(
[id] => 13574837
[patent_doc_number] => 20180338967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => OXYMORPHONE CONTROLLED RELEASE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/049390
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/049390 | OXYMORPHONE CONTROLLED RELEASE COMPOSITIONS | Jul 29, 2018 | Abandoned |
Array
(
[id] => 16776386
[patent_doc_number] => 20210113463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Injectable Water-in-oil Emulsions And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/630456
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630456 | Injectable water-in-oil emulsions and uses thereof | Jul 15, 2018 | Issued |
Array
(
[id] => 13790439
[patent_doc_number] => 20190008758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => LACOSAMIDE CONTROLLED RELEASE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/027963
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16027963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/027963 | LACOSAMIDE CONTROLLED RELEASE FORMULATION | Jul 4, 2018 | Abandoned |
Array
(
[id] => 14372251
[patent_doc_number] => 20190160038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/026546
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16026546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/026546 | Nanoparticle isoflavone compositions and methods of making and using the same | Jul 2, 2018 | Issued |
Array
(
[id] => 14403637
[patent_doc_number] => 20190167662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/017099
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017099
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017099 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | Jun 24, 2018 | Abandoned |
Array
(
[id] => 13729537
[patent_doc_number] => 20180369236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/017097
[patent_app_country] => US
[patent_app_date] => 2018-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017097
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/017097 | TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | Jun 24, 2018 | Abandoned |
Array
(
[id] => 13424977
[patent_doc_number] => 20180264031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => CHOLESTYRAMINE PELLETS AND METHODS FOR PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/988688
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988688
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988688 | CHOLESTYRAMINE PELLETS AND METHODS FOR PREPARATION THEREOF | May 23, 2018 | Abandoned |